Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
Crossref DOI link: https://doi.org/10.1007/s00259-017-3688-2
Published Online: 2017-03-31
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Del Prete, Michela
Buteau, François-Alexandre
Beauregard, Jean-Mathieu http://orcid.org/0000-0003-2123-145X
Funding for this research was provided by:
Institute of Cancer Research (MOP-142233)
License valid from 2017-03-31